Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Nontransfusional approach to increased platelet count in patients with cirrhosis and thrombocytopenia.

Tripodi A, Primignani M.

Hepatology. 2013 Sep;58(3):1177-80. doi: 10.1002/hep.26502. Epub 2013 Jul 29. No abstract available.

PMID:
23703879
2.

Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.

Violi F, Pignatelli P.

N Engl J Med. 2012 Nov 22;367(21):2056. doi: 10.1056/NEJMc1211471#SA2. No abstract available.

PMID:
23171115
3.

Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.

Lisman T, Porte RJ.

N Engl J Med. 2012 Nov 22;367(21):2055-6. doi: 10.1056/NEJMc1211471#SA1. No abstract available.

PMID:
23171114
4.

Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.

Afdhal NH, Giannini EG, Tayyab G, Mohsin A, Lee JW, Andriulli A, Jeffers L, McHutchison J, Chen PJ, Han KH, Campbell F, Hyde D, Brainsky A, Theodore D; ELEVATE Study Group.

N Engl J Med. 2012 Aug 23;367(8):716-24. doi: 10.1056/NEJMoa1110709.

5.

Eltrombopag in thrombocytopenia.

Lawson A.

N Engl J Med. 2008 Mar 6;358(10):1072; author reply 1072-3. doi: 10.1056/NEJMc073571. No abstract available.

6.

Immune thrombocytopenic purpura--from agony to agonist.

Schwartz RS.

N Engl J Med. 2007 Nov 29;357(22):2299-301. No abstract available.

PMID:
18046034
7.

Potential usefulness of thrombopoietin receptor agonists in haemophiliacs with thrombocytopaenia due to chronic liver disease.

Aguilar C.

Blood Coagul Fibrinolysis. 2013 Apr;24(3):231-6. doi: 10.1097/MBC.0b013e3283606a0b. Review.

PMID:
23518832
8.

Use of eltrombopag for the treatment of thrombocytopenia in hypoplastic myelodysplastic syndrome.

Gauchan D, Shaaban H, Gedeon D, Maroules M.

Ann Hematol. 2014 Oct;93(10):1777-8. doi: 10.1007/s00277-014-2032-1. Epub 2014 Feb 20. No abstract available.

PMID:
24554304
9.

Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.

McHutchison JG, Dusheiko G, Shiffman ML, Rodriguez-Torres M, Sigal S, Bourliere M, Berg T, Gordon SC, Campbell FM, Theodore D, Blackman N, Jenkins J, Afdhal NH; TPL102357 Study Group.

N Engl J Med. 2007 Nov 29;357(22):2227-36.

10.

Successful platelet count recovery in lupus-associated thrombocytopenia with the thrombopoietin agonist eltrombopag.

Scheinberg P, Singulane CC, Barbosa LS, Scheinberg M.

Clin Rheumatol. 2014 Sep;33(9):1347-9. doi: 10.1007/s10067-014-2600-8. Epub 2014 Apr 17.

PMID:
24740463
11.

Eltrombopag in thrombocytopenia.

Zimmer J, Hentges F, Andrès E.

N Engl J Med. 2008 Mar 6;358(10):1072; author reply 1072-3. No abstract available.

PMID:
18326076
12.

Thrombopoietin-receptor agonists in children with immune thrombocytopenia.

Neunert CE, Grace RF.

Lancet. 2015 Oct 24;386(10004):1606-9. doi: 10.1016/S0140-6736(15)61223-5. Epub 2015 Jul 28. No abstract available.

PMID:
26231462
13.

Molecule of the month. Eltrombopag.

[No authors listed]

Drug News Perspect. 2008 Jul-Aug;21(6):344. No abstract available.

PMID:
18836592
14.

Is treatment of moderate thrombocytopenia indicated for patients with HCV infection and cirrhosis?

Desborough MJ, Jairath V.

Gastroenterology. 2014 Jul;147(1):254. doi: 10.1053/j.gastro.2014.02.058. Epub 2014 May 27. No abstract available.

PMID:
24877869
15.

Usage of eltrombopag for chronic immune thrombocytopenia as a pretreatment for splenectomy.

Uwagawa T, Misawa T, Furukawa K, Ito R, Futagawa Y, Yahagi Y, Aiba K, Yanaga K.

Acta Haematol. 2013;129(1):45-7. doi: 10.1159/000342105. Epub 2012 Oct 31. No abstract available.

PMID:
23128016
16.

Eltrombopag for thrombocytopenic patients with hepatitis C virus infection and cirrhosis.

Ji F, Deng H, Li Z.

Gastroenterology. 2014 Jul;147(1):253-4. doi: 10.1053/j.gastro.2013.12.046. Epub 2014 May 27. No abstract available.

PMID:
24877867
17.

Do we have to worry for thrombocytopenia during treatment of hepatitis C.

Ince AT.

Turk J Gastroenterol. 2014 Jun;25(3):344-5. doi: 10.5152/tjg.2014.0012. No abstract available.

18.

Reply: To PMID 24126097.

Afdhal NH, Theodore D.

Gastroenterology. 2014 Jul;147(1):255-6. doi: 10.1053/j.gastro.2014.05.030. Epub 2014 May 27. No abstract available.

PMID:
24877870
19.

Eltrombopag for thrombocytopenic patients with chronic HCV infection.

Maan R, Veldt BJ, Janssen HL.

Gastroenterology. 2014 Jul;147(1):254-5. doi: 10.1053/j.gastro.2014.01.070. Epub 2014 May 27. No abstract available.

PMID:
24877871
20.

Successful treatment of severe thrombocytopenia with the use of thrombopoeitin receptor agonist eltrombopag in a patient with chronic myelomonocytic leukemia.

Modi Y, Shaaban H, Gauchan D, Maroules M.

J Oncol Pharm Pract. 2015 Feb;21(1):74-5. doi: 10.1177/1078155214544076. Epub 2014 Jul 24.

PMID:
25063763

Supplemental Content

Support Center